All lobbying filings
THE WASHINGTON TAX & PUBLIC POLICY GROUP
Lobbying for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION · Biopharmaceutical industry
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 8, 2025
Income
$70,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Lobbyists on this filing
2
-
GREGORY NICKERSONPreviously held: Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee
-
JAMES MAX PEDROTTI New on this filingPreviously held: Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of Staff to Rep. Carol Miller
Government bodies contacted
2
Lobbying activity
1
Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations and agreements on the taxation of global income and the potential impacts on the tax base of the U.S. and its Territories. Issues related to IRC sections 11, 164(a), 951A, 250, 59A, 163(j), 168(k), 174, and 41. (H.R.1990, H.R. 574, H.R. 1062, S. 187, S. 1605, S. 2021, H.R. 1 - Sections 70301, 70302, 70321, 70322, 70323, 70331, 70361). Issues related to interest deductibility. (H.R. 1347, S. 559, S. 1688, H.R. 1 - Section 70303)